Skip to main content
Caplight Logo









Ignota Labs

Ignota Labs

Private
CambridgeHealthcare & Life Scienceshttps://www.ignotalabs.ai/

Last Round

Seed

Feb 26, 2025

Total Funding Raised

$6.9M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Ignota Labs is a biotechnology company that utilizes its proprietary AI platform, SAFEPATH, to identify and mitigate toxicity issues in promising drugs that were abandoned during clinical trials.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS, Revenue Share

AI Layer

Application

Keywords

drug discoveryAI drug discoverydrug toxicitydrug repurposingclinical trial failurebioinformaticscheminformaticsmolecular re-engineeringdrug turnaroundbiotech AIin silico drug designpredictive toxicologybiopharmaasset rescue

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ignota Labs Comparables

Compare Ignota Labs with similar companies based on industry and business-model similarity.

Ignota Labs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sentinus.AI
86%
DeepCyte
80%
Biossil Inc.
78%

Ignota Labs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 26, 2025

Key People

Founding team and executive leadership

Layla Hosseini-Gerami

Co-Founder And Chief Data Science Officer

Founding Team

Sam Windsor

Co-CEO And Commercial Lead

Executive Team

Ignota Labs Investors

Notable investors and investment history

Ignota Labs investors
InvestorRounds
Montage VenturesSeed
GaingelsSeed
Blue Wire CapitalSeed
Modi VenturesSeed
AIX VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors increased 31% MoM, reaching 3.3K.

  • Feb 26, 2025

    $7M raised in Seed round.

Ignota Labs Filings

Explore SEC and related filing metadata, where available.

Ignota Labs filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ignota Labs's valuation, stock price, and market status.

Is Ignota Labs a public or private company?

Ignota Labs is a private company.

What is the current stock price of Ignota Labs?

Ignota Labs is a private company with no public stock price. No recent secondary market data is available.

How much is Ignota Labs worth (valuation)?

Valuation information for Ignota Labs is not publicly available.

Can I buy Ignota Labs stock?

Ignota Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ignota Labs's last funding round?

Ignota Labs's most recent funding round was Seed on February 26, 2025.

Who are the main investors in Ignota Labs?

Key investors in Ignota Labs include Montage Ventures, AIX Ventures.

Will Ignota Labs IPO soon?

No public IPO plans have been announced for Ignota Labs.

How can I track Ignota Labs secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ignota Labs's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge
Employee Range20
Year Founded2021
Last FundingFeb 26, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?